Home > News > featured news > Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

Government Business

Valneva and Scottish Enterprise in Advanced Discussions for Major Grant to Complete Livingston Site

Valneva | December 24, 2021

Valneva SE , a specialty vaccine company, today announced that it is in advanced discussions, with Scottish Enterprise, for a multi-million pound grant which will enable it to fully complete its strategic manufacturing site in Livingston, Scotland.

Following the termination of the supply agreement with the UK Government (HMG) for Valneva’s inactivated COVID-19 vaccine candidate, VLA2001, Valneva paused its site plans. Valneva and Scottish Enterprise have since engaged in a highly constructive dialogue, and under the proposed grant, the Livingston site will be fully developed as a key vaccine production site for the long term.

Both Valneva and Scottish Enterprise would invest in the plant. Scottish Enterprise’s contribution is expected to be through a series of grants totalling £10-20 million to enable Valneva to commence production at the plant. Discussions between the Company and the Scottish Government also include potential supply of VLA2001 for Scotland in the future, subject to regulatory approval. Valneva has also offered to make up to 25,000 doses of VLA2001 available for primary immunisation, free of charge, to National Health Service and frontline workers in Scotland, subject to regulatory approval. The grant is subject to contract and final due diligence and is expected to include commitments to jobs for the future in Livingston.

Commenting, David Lawrence, Acting Chief Financial Officer, said “We’re pleased that we’ve been able to advance discussions with Scottish Enterprise quickly, following the UK Government’s unexpected decision to terminate our supply agreement with them. We’ve reported excellent Phase 3 data and homologous booster data in the past couple of months, underlining the potential importance of VLA2001 – our inactivated, adjuvanted whole virus vaccine. Subject to regulatory approval we want to make VLA2001 available to people who need it, as soon as we can. We already have some vaccine stock available for distribution, upon approval. The grant will be very welcome and, subject to contract, will ensure that Livingston becomes a strategic vaccine manufacturing site for the future, successfully completing the work we began with HMG”.

Ivan McKee, Scottish Government Minister for Business, Trade, Tourism and Enterprise, said “Valneva is a valued contributor to our life sciences sector and the Livingston facility is an important asset, developing vaccines for the treatment of several important infectious diseases and supporting high quality jobs. Ministers and Scottish Enterprise are in advanced discussions with the company to agree a package of support which would underpin the company’s operations in Scotland.”

Hannah Bardell, MP for Livingston, added “I am delighted that the Scottish Government and Scottish Enterprise have listened to my constituency colleagues and I by agreeing to invest in Valneva’s vaccine manufacturing site in Livingston. This funding will enable Valneva to complete its expansion, boosting vital production capacity and protecting skilled jobs. It has been a pleasure to work with all involved in securing this agreement and I can only hope the UK Government will see the faith that we in Scotland have in Valneva.”

Valneva is continuing to try to reach an amicable resolution with HMG regarding its termination of the supply agreement and performance of the ongoing clinical trial agreement. The Company continues to reserve all rights in the event that an amicable outcome is not achieved.

About VLA2001
VLA2001 is currently the only whole virus, inactivated, adjuvanted vaccine candidate against COVID-19 in clinical trials in Europe. It is intended for active immunization of at-risk populations to prevent carriage and symptomatic infection with COVID-19 during the ongoing pandemic and potentially later for routine vaccination including addressing new variants. VLA2001 may also be suited for boosting, as repeat booster vaccinations have been shown to work well with whole virus inactivated vaccines. VLA2001 is produced on Valneva’s established Vero-cell platform, leveraging the manufacturing technology for Valneva’s licensed Japanese encephalitis vaccine, IXIARO®. VLA2001 consists of inactivated whole virus particles of SARS-CoV-2 with high S-protein density, in combination with two adjuvants, alum and CpG 1018. This adjuvant combination has consistently induced higher antibody levels in preclinical experiments than alum-only formulations and shown a shift of the immune response towards Th1. CpG 1018 adjuvant, supplied by Dynavax Technologies Corporation (Nasdaq: DVAX), is a component of the US FDA- and EMA-approved HEPLISAV-B® vaccine.

About Valneva SE
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company takes a highly specialized and targeted approach to vaccine development and then applies its deep understanding of vaccine science to develop prophylactic vaccines addressing these diseases. Valneva has leveraged its expertise and capabilities both to successfully commercialize two vaccines and to rapidly advance a broad range of vaccine candidates into and through the clinic, including candidates against Lyme disease, the chikungunya virus and COVID-19.

Spotlight

More featured news

Spotlight

Related News

Emerging Technology, Cybersecurity

OwnBackup Achieves FedRAMP® Authorized Designation

Businesswire | July 20, 2023

OwnBackup, the leading SaaS data protection platform, today announced it has achieved FedRAMP® authorization for its OwnBackup Government Cloud solution. With this authorization, OwnBackup is now listed on the FedRAMP® Marketplace, and is eligible to provide data protection services to all U.S. Federal Government customers. Established in 2011, FedRAMP® is a government-wide program that promotes the adoption of secure Cloud services across the Federal Government, forming a public-private partnership to promote innovation and the advancement of more secure information technologies. By achieving FedRAMP® authorization, OwnBackup has demonstrated that it meets the rigorous security and compliance requirements of the program to host sensitive information in the Cloud. “FedRAMP® authorization is a significant milestone for OwnBackup, and reaffirms our position as the market leader in SaaS data protection,” said Sam Gutmann, Chief Executive Officer at OwnBackup. “This designation allows us to bring our best-in-class solutions to Federal Government agencies, partnering with these vital organizations to accelerate their digital transformation goals, while ensuring that critical Federal Data and Metadata remains secure.” OwnBackup’s FedRAMP® announcement comes at a time when the U.S. Government is making cybersecurity a clear priority. Earlier this year, the Biden-Harris Administration announced a new National Cybersecurity Strategy focused on strengthening the Nation's digital infrastructure, emphasizing the importance of Cloud security and resilience, and protecting citizens and businesses from cyber threats. While no individual or company is immune to cyber threats, these attacks disproportionately target the public sector. The public sector manages a wide array of sensitive information, making it a popular target for cyber criminals. According to Verizon’s 2022 Data Breach Investigations Report (DBIR), the public sector had the second most attacks of any industry. With OwnBackup, U.S. Government Agencies can be better prepared to avoid disruption to critical services, ensure a continuity of operations, and uphold trust and confidence with the citizens that they serve. OwnBackup’s Data Protection Platform, which is used by over 6,000 customers across critical SaaS ecosystems, was designed with security in mind from its inception. OwnBackup’s solutions are architected with a variety of security controls across multiple tiers to address a range of security risks. About OwnBackup OwnBackup is a leading SaaS data protection platform for some of the largest SaaS ecosystems in the world, including Salesforce, Microsoft Dynamics 365, and ServiceNow. Through capabilities like data security, backup and recovery, archiving, and sandbox seeding, OwnBackup empowers thousands of organizations worldwide to manage and protect the mission-critical data that drives their business. Co-founded by seasoned data recovery, data protection, and information security experts, OwnBackup is a trusted independent software vendor (ISV) partner on the Salesforce AppExchange, AWS Marketplace, and Microsoft Marketplace. The Company is headquartered in Englewood Cliffs, New Jersey, with research and development (R&D), support, and other functions in Israel, EMEA and APAC. OwnBackup has raised over $500 million in venture funding, is ranked on the Forbes Cloud 100 as one of the world's top private cloud companies, and is the partner of choice for some of the world’s largest users of SaaS applications.

Emerging Technology, Government Business

CSG Government Solutions Selected for Program Management Office Services on the Connecticut Medicaid Enterprise Technology System Program

Prweb | August 03, 2023

CSG Government Solutions, a national leader in government program modernization, today announced that it has been selected by the Connecticut Department of Social Services (DSS) to provide Program Management and Project Support Services for the Connecticut Medicaid Enterprise Technology System (CT METS) Program, including the implementation of an Enterprise Data Warehouse and Analytics module and Enterprise Provider module. CSG is supporting DSS’ initiative to replace their core MMIS and other systems supporting the Medicaid Enterprise with modern, modular solutions. The CSG team will provide full-service Program Management Office (PMO) services and expertise in Medicaid, enterprise architecture, system integration, Health Information Exchange, and security. The team is also providing quality assurance, risk management, schedule and resource management, and CMS certification support. “CSG is a leader in providing PMO and other services for Medicaid system modernizations across the country,” says Robin Dufresne, Executive Vice President and Senior Practice Director. “Our team applies our Medicaid expertise and dedication to help the DSS Medicaid Enterprise make a positive impact on the health and well-being of Connecticut’s individuals, families, and communities.” About CSG Government Solutions CSG Government Solutions is a leading government operations consulting firm helping states modernize critical program enterprises. We help governments leverage innovative technology and processes to meet the challenges of administering complex programs. Founded in 1997, CSG clients include 47 state and territory governments, the U.S. Department of Health and Human Services, the U.S. Department of Labor, and large municipal governments. For more information, visithttp://www.csgdelivers.comand connect with us onLinkedInandTwitter.

Emerging Technology

Hughes Awarded Space Force IDIQ Contract for Low Earth Orbit (LEO) Satellite Services

PR Newswire | August 23, 2023

Hughes Network Systems LLC, an EchoStar company, today announced that it has been awarded a five-year, Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Space Force for proliferated Low Earth Orbit (LEO) satellite-based services. Under the IDIQ vehicle, valued at up to $900 million, U.S. Department of Defense, other federal agencies and international coalition partners can procure fully managed, low-latency LEO services from Hughes leveraging capacity on two constellations: OneWeb and EchoStar Lyra™. "As government and defense agencies explore the power and potential of LEO services in delivering capabilities to the warfighter faster and at lower cost, we're proud to offer not one, but two compelling solutions," said Leslie Blaker-Glass, vice president, Hughes. "Our OneWeb offering – with our low-power, light-weight, flat panel antenna – and our next-generation EchoStar Lyra S-band IoT system position us to deliver customers in the DoD and federal government robust and resilient low-latency connectivity at a competitive price." Hughes previously announced a distribution agreement with OneWeb Technologies Inc., a wholly owned subsidiary of OneWeb, to deliver managed, wideband LEO services to the DoD; those services are now available under the IDIQ and the GSA Schedule. Also available under the IDIQ are narrowband services over the EchoStar Lyra constellation, the system that EchoStar, parent company of Hughes, is developing for Internet of Things (IoT) connectivity and ongoing market development that includes 5G non-terrestrial networks (NTN). "These important LEO capabilities will give the DoD cost-effective solutions and added reliability and resiliency in satellite communications across all domains and we look forward to addressing upcoming requirements for procurement of these services," added Rick Lober, vice president and general manager, Defense and Government Systems Division, Hughes. About Hughes Hughes Network Systems LLC, an EchoStar company, provides broadband equipment and services; managed services featuring smart, software-defined networking; and end-to-end network operation for millions of consumers, businesses, governments and communities worldwide. The Hughes flagship internet service, HughesNet®, connects millions of people across the Americas, and the Hughes JUPITER™ System powers internet access for tens of millions more worldwide. Hughes supplies more than half the global satellite terminal market to leading satellite operators, in-flight service providers, mobile network operators and military customers. A managed network services provider, Hughes supports approximately half a million enterprise sites with its HughesON™ portfolio of wired and wireless solutions.